Cargando…
Salt and sugar: Bad company
This report shed light to unrecognized mechanism for the hyperglycemia‐induced sodium retention. The activation of PPAR?, elevation of serum adiponectin, and subsequent inhibition of SGLT2 may lead to natriuresis and glycosuria and it may be beneficial in hypertensive diabetic patients. [Image: see...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217884/ https://www.ncbi.nlm.nih.gov/pubmed/27415769 http://dx.doi.org/10.1111/jdi.12553 |
_version_ | 1782492169578217472 |
---|---|
author | Wada, Jun |
author_facet | Wada, Jun |
author_sort | Wada, Jun |
collection | PubMed |
description | This report shed light to unrecognized mechanism for the hyperglycemia‐induced sodium retention. The activation of PPAR?, elevation of serum adiponectin, and subsequent inhibition of SGLT2 may lead to natriuresis and glycosuria and it may be beneficial in hypertensive diabetic patients. [Image: see text] |
format | Online Article Text |
id | pubmed-5217884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-52178842017-01-09 Salt and sugar: Bad company Wada, Jun J Diabetes Investig Commentaries This report shed light to unrecognized mechanism for the hyperglycemia‐induced sodium retention. The activation of PPAR?, elevation of serum adiponectin, and subsequent inhibition of SGLT2 may lead to natriuresis and glycosuria and it may be beneficial in hypertensive diabetic patients. [Image: see text] John Wiley and Sons Inc. 2016-08-30 2017-01 /pmc/articles/PMC5217884/ /pubmed/27415769 http://dx.doi.org/10.1111/jdi.12553 Text en © 2016 The Author. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Commentaries Wada, Jun Salt and sugar: Bad company |
title | Salt and sugar: Bad company |
title_full | Salt and sugar: Bad company |
title_fullStr | Salt and sugar: Bad company |
title_full_unstemmed | Salt and sugar: Bad company |
title_short | Salt and sugar: Bad company |
title_sort | salt and sugar: bad company |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217884/ https://www.ncbi.nlm.nih.gov/pubmed/27415769 http://dx.doi.org/10.1111/jdi.12553 |
work_keys_str_mv | AT wadajun saltandsugarbadcompany |